Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Diaceutics PLC

Market Cap 12Cr 16Cr 14Cr 13Cr 23Cr 1.54TCr 23Cr 152.2Cr 59Cr 749.27Cr 61Cr 59Cr 2.59TCr P/E Ratio 2025 *
-
P/E Ratio 2026 * -
Enterprise Value 11Cr 15Cr 13Cr 12Cr 21Cr 1.42TCr 21Cr 140.29Cr 55Cr 690.65Cr 56Cr 55Cr 2.39TCr EV / Sales 2025
2.64x
EV / Sales 2026 * 2.4x
Free-Float
71.33%
Yield 2025 *
-
Yield 2026 * -
1 week+0.71%
Current month-0.35%
1 month-17.15%
3 months-2.40%
6 months+2.52%
Current year+11.33%
1 week 136
Extreme 136
144
1 month 136
Extreme 136
174
Current year 125
Extreme 125
180
1 year 112.25
Extreme 112.25
180
3 years 82
Extreme 82
180
5 years 74
Extreme 74
180
10 years 74
Extreme 74
195
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Date Insider Type Main position Quantity % Market Cap.
05/05Buy

Chief Financial Officer

90 0.0001%
05/05Free

Chief Financial Officer

90 0.0001%
05/05Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.71%+13.55%+65.70% 16Cr
+4.55%+2.00%+393.02%+1,126.82% 5.95TCr
+0.82%-7.40%+21.95%+38.81% 393.83Cr
-1.09%-14.85%+26.49%+86.17% 327.5Cr
+2.61%-4.29%-31.77%+15.87% 135.45Cr
+1.37%-2.72%-20.98%-56.83% 130.42Cr
0.00%-1.65%+30.96%+236.62% 122.08Cr
+4.48%+0.38%-29.07%+40.88% 113.49Cr
-0.83%-4.75%-30.79%-55.78% 107.36Cr
Average +1.32%-2.32%+41.48%+166.47% 810.64Cr
Weighted average by Cap. +3.84%+0.93%+321.55%+928.05%

Financials

2025 2026 *
Net sales 3.85Cr 5.17Cr 4.46Cr 4.11Cr 7.22Cr 491.24Cr 7.33Cr 49Cr 19Cr 239.11Cr 19Cr 19Cr 827.91Cr 4.7Cr 6.31Cr 5.45Cr 5.02Cr 8.81Cr 599.67Cr 8.94Cr 59Cr 23Cr 291.88Cr 24Cr 23Cr 1.01TCr
Net income -4L -5L -5L -4L -7L -5.1Cr -8L -50.46L -19.67L -2.48Cr -20.15L -19.72L -8.6Cr -11L -14.77L -12.75L -11.75L -20.61L -14Cr -20.93L -1.39Cr -54.1L -6.83Cr -55.41L -54.23L -24Cr
Net Debt -94.39L -1.27Cr -1.09Cr -1.01Cr -1.77Cr -120.43Cr -1.8Cr -12Cr -4.64Cr -59Cr -4.75Cr -4.65Cr -202.96Cr -77.1L -1.03Cr -89.39L -82.37L -1.44Cr -98Cr -1.47Cr -9.73Cr -3.79Cr -48Cr -3.88Cr -3.8Cr -165.79Cr
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
12/26/12 142.50 p 0.00% 4,84,139
11/26/11 142.50 p 0.00% 1,26,613
10/26/10 142.50 p -0.35% 2,86,175
09/26/09 143.00 p 0.00% 2,01,399
08/26/08 143.00 p +1.06% 2,21,249
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.425GBP
Average target price
2.130GBP
Spread / Average Target
+49.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXRX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!